Reed Smith LLP | USA | 9 May 2022
We have posted twice before about decisions that reject duty-to-train claims under the rubric of “educational malpractice.” Now Pennsylvania has…
Reed Smith LLP | USA | 2 May 2022
As regular readers know, we bloggers have been following the issue of whether software of various sorts - electronic bytes - is a “product” for…
Reed Smith LLP | USA | 25 Apr 2022
Federal Rule of Evidence 407, dealing with the inadmissibility of subsequent remedial measures, isn’t all that complicated - as Federal Rules go…
Reed Smith LLP | USA | 18 Apr 2022
A few years ago we did a couple of posts about the learned intermediary decision that arose from the Zimmer Nexgen Knee Implant MDL, and was…
Reed Smith LLP | USA | 12 Apr 2022
One of the problems with so-called Lone Pine orders in MDLs is timing - they are usually entered way too late, more as vehicles to enforce settlements…
Reed Smith LLP | USA | 11 Apr 2022
We had occasion recently to reread Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), and here’s what the Court said about why the “reasonable assurance…
Reed Smith LLP | USA | 8 Apr 2022
We have decried several times plaintiffs’ tendency in prescription medical product litigation, particularly mass torts, to try to sue into submission…
Reed Smith LLP | USA | 1 Apr 2022
Counsel defending depositions have a decision to make - whether, after opponent’s the direct examination of the witness is complete, whether to…
Reed Smith LLP | USA | 31 Mar 2022
This post is from the non-Dechert side of the blog. Our latest Zantac litigation decision is not from the Florida MDL, but rather a standalone case…
Reed Smith LLP | USA | 31 Mar 2022
The Orthopedic Bone Screw would never have occurred - and Bexis might never have found his way to prescription medical product liability litigation -…